Patricia Collins

Dr. Patricia Collins


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2016 in Cells
Verified
Journal Article
Open access
PDF file
PCPatricia Collins
Patricia Collins
IMIzaskun Mitxitorena
Izaskun Mitxitorena
Ruaidhri CarmodyRuaidhri Carmody
Ruaidhri Carmody
Nuclear factor (NF)-κB has evolved as a latent, inducible family of transcription factors fundamental in the control of the inflammatory response. The transcription of hundreds of genes involved in inflammation and immune homeostasis require NF-κB, necessitating the need for its strict control. The inducible ubiquitination and proteasomal degradation of the cytoplasmic inhibitor of κB (IκB) proteins promotes the nuclear translocation and transcriptional activity of NF-κB. More recently, an additional role for ubiquitination in the regulation of NF-κB activity has been identified. In this case, the ubiquitination and degradation of the NF-κB subunits themselves plays a critical role in the termination of NF-κB activity and the associated transcriptional response. While there is still much to discover, a number of NF-κB ubiquitin ligases and deubiquitinases have now been identified which coordinate to regulate the NF-κB transcriptional response. This review will focus the regulation of NF-κB subunits by ubiquitination, the key regulatory components and their impact on NF-κB directed transcription.

1 March 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PCPatricia Collins
Patricia Collins
PKPatrick A. Kiely
Patrick A. Kiely
Ruaidhri CarmodyRuaidhri Carmody
Ruaidhri Carmody
B cell leukemia 3 (Bcl-3) is an essential negative regulator of NF-κB during Toll-like receptor and TNF receptor signaling. Bcl-3 also interacts with a number of transcriptional regulators, including homodimers of the NF-κB p50 subunit. Deletion of Bcl-3 results in increased NF-κB p50 ubiquitination and proteasomal degradation and increased inflammatory gene expression. We employed immobilized peptide array technology to define a region of p50 required for the formation of a Bcl-3·p50 homodimer immunosuppressor complex. Our data demonstrate that amino acids 359-361 and 363 of p50 are critical for interaction with Bcl-3 and essential for Bcl-3-mediated inhibition of inflammatory gene expression. Bcl-3 is unable to interact with p50 when these amino acids are mutated, rendering it incapable of inhibiting the transcriptional activity of NF-κB. Bcl-3 interaction-defective p50 is hyperubiquitinated and has a significantly reduced half-life relative to wild-type p50. Nfkb1(-/-) cells reconstituted with mutated p50 precursor p105 are hyperresponsive to TNFα stimulation relative to wild-type p105, as measured by inflammatory gene expression. Mutant p105 recapitulates a Bcl3(-/-) phenotype. This study demonstrates that interaction with p50 is necessary and sufficient for the anti-inflammatory properties of Bcl-3 and further highlights the importance of p50 homodimer stability in the control of NF-κB target gene expression.

1 January 2015 in Critical Reviews in Immunology
Verified
Journal Article
Closed access
PDF file
PCPatricia Collins
Patricia Collins
RCRuaidhri J. Carmody
Ruaidhri J. Carmody
Endotoxin tolerance in macrophages is a key regulatory mechanism to limit the innate immune response to infection or injury. Long considered a state of unresponsiveness to Toll-like receptor activation, tolerance is now recognized as a state of altered responsiveness to infection or injury. Endotoxin tolerance leads to a shift away from a pro-inflammatory response toward a response with key anti-inflammatory and pro-resolution features. Advances in our understanding of Toll-like receptor function have identified a number of molecular mechanisms that promote tolerance, but how these are integrated to achieve gene-specific regulation is an important outstanding question. The potential to harness the mechanisms of endotoxin tolerance to promote the resolution of chronic inflammation warrants the continued investigation of this fundamental feature of innate immunity. This review focuses on the endotoxin tolerant state, our understanding of the underlying molecular mechanisms, and the clinical significance of endotoxin tolerance.

1 June 2015 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
PCPatricia Collins
Patricia Collins
GGGianluca Grassia
Gianluca Grassia
ACAmy Colleran
Amy Colleran
PKPatrick A. Kiely
Patrick A. Kiely
AIArmando Ialenti
Armando Ialenti
Ruaidhri CarmodyRuaidhri Carmody
Ruaidhri Carmody
The NF-κB transcriptional response is tightly regulated by a number of processes including the phosphorylation, ubiquitination and subsequent proteasomal degradation of NF-κB subunits. The IκB family protein Bcl-3 stabilises a NF-κB p50 homodimer:DNA complex through inhibition of p50 ubiquitination. This complex inhibits the binding of the transcriptionally active NF-κB subunits p65 and c-Rel on the promoters of NF-κB target genes and functions to suppress inflammatory gene expression. We have previously shown that the direct interaction between p50 and Bcl-3 is required for Bcl-3 mediated inhibition of pro-inflammatory gene expression. In this study we have used immobilised peptide array technology to define regions of Bcl-3 that mediate interaction with p50 homodimers. Our data shows that Bcl-3 makes extensive contacts with p50 homodimers and in particular with ankyrin repeat (ANK) 1, 6 and 7, and the N terminal region of Bcl-3. Using this data we have designed a Bcl-3 mimetic peptide based on a region of the ANK1 of Bcl-3 that interacts with p50 and which shares low sequence similarity with other IκB proteins. When fused to a cargo carrying peptide sequence this Bcl-3 derived peptide, but not a mutated peptide, inhibited Toll-like receptor induced cytokine expression in vitro. The Bcl-3 mimetic peptide was also effective in preventing inflammation in vivo in the carrageenan-induced paw edema mouse model. This study demonstrates that therapeutic strategies aimed at mimicking the functional activity of Bcl-3 may be effective in the treatment of inflammatory disease.